小RNA
癌症
淋巴瘤
白血病
无症状携带者
急性白血病
成人T细胞白血病/淋巴瘤
生物信息学
医学
生物
疾病
机器学习
计算生物学
基因
免疫学
病理
T细胞白血病
内科学
计算机科学
遗传学
作者
Mohadeseh Zarei Ghobadi,Rahman Emamzadeh,Elaheh Afsaneh
出处
期刊:BMC Cancer
[BioMed Central]
日期:2022-04-21
卷期号:22 (1)
被引量:13
标识
DOI:10.1186/s12885-022-09540-1
摘要
Adult T-cell Leukemia/Lymphoma (ATLL) is a cancer disease that is developed due to the infection by human T-cell leukemia virus type 1. It can be classified into four main subtypes including, acute, chronic, smoldering, and lymphoma. Despite the clinical manifestations, there are no reliable diagnostic biomarkers for the classification of these subtypes.Herein, we employed a machine learning approach, namely, Support Vector Machine-Recursive Feature Elimination with Cross-Validation (SVM-RFECV) to classify the different ATLL subtypes from Asymptomatic Carriers (ACs). The expression values of multiple mRNAs and miRNAs were used as the features. Afterward, the reliable miRNA-mRNA interactions for each subtype were identified through exploring the experimentally validated-target genes of miRNAs.The results revealed that miR-21 and its interactions with DAAM1 and E2F2 in acute, SMAD7 in chronic, MYEF2 and PARP1 in smoldering subtypes could significantly classify the diverse subtypes.Considering the high accuracy of the constructed model, the identified mRNAs and miRNA are proposed as the potential therapeutic targets and the prognostic biomarkers for various ATLL subtypes.
科研通智能强力驱动
Strongly Powered by AbleSci AI